Geaton and JoAnn DeCesaris Cancer Center Institute Cancer Registry 2016 Annual Report
Schedule a consultation at the DeCesaris Cancer Institute in Annapolis.
In the past few years, prostate cancer has become more of a chronic disease than a life-threatening event. In fact, our urologic oncologists, the doctors who lead prostate treatment, have many more “watchful waiting” conversations with men than ever before. Watchful waiting is a form of conservative management, which involves monitoring hormones and the growth of the tumor for a period of time before deciding on a course of action.
More men are diagnosed with cancer of the prostate, the male sex gland located in front of the bladder, than with any other cancer other than skin cancer. The walnut-sized prostate is one of the organs that helps make seminal fluid, and a tumor located in the prostate can impair urination and normal sexual function. As men age, malignancies of the prostate become more likely; while 1 in 4 50-year-old men may have some cancerous cells, the risk increases to 1 in 2 by age 80.
The good news is that the vast majority of prostate cancers are discovered early, while the majority of malignant cells are confined to the prostate. At this stage of the disease, the five-year survival rate is between 95-100%. With early diagnosis, a range of effective treatment options is available, ranging from conservative management (sometimes called watchful waiting) to removal of the prostate.
At our Program, all of our urologic oncologists are board-certified, adding additional training and experience to their approach to your treatment. We follow the latest evidence-based medicine guidelines for prostate cancer treatment, which means our doctors follow the latest medical research on the best approaches to different presentations of prostate cancer (size, type of tumor, how fast it is growing).
Our urologists, surgeons, radiation oncologists and medical oncologists collaborate to develop treatment plans, discussing options and formulating the best approach for nerve-sparing care created personally for you.
We have several advanced treatments available, including the use of prostate brachytherapy, which is the placement of radioactive “seeds” near the prostate to destroy the cancer cells. Our surgeons are also experts in using the daVinci® Surgical System, a minimally invasive approach to prostate cancer treatment, which speeds recovery and helps maintain full function after treatment.
Our physicians are involved in a wide variety of research opportunities and clinical trials, giving our patients access to cutting-edge technologies and treatment offerings. Patients have the option to participate in research conducted at AAMC and at other locations across the nation.
In addition, the Anne Arundel Health System Research Institute has been named the inaugural affiliate of the Johns Hopkins Clinical Research Network. The network’s goal is to allow patients at regional health systems such as AAMC to benefit from their advances in areas such as diagnostic, treatment, and disease prevention. This affiliation gives our patients access to authoritative clinical research and an even wider range of options in patient care. Learn more about our research.
Learn more about prostate cancer: